Back to Search
ELLEN VORONOV, M.D.
M.D.
Physical Medicine & Rehabilitation Physician
NPI: 1730170523IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pain Medicine (Physical Medicine & Rehabilitation) Physician
Physical Medicine & Rehabilitation — Pain Medicine
Code: 2081P2900X
036101656(IL)
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
036101656(IL)
Education
OTHER
Class of 1996
Research & Publications (20)
Role of IL-1-mediated inflammation in tumor angiogenesis.
PMID 17713014·Adv Exp Med Biol·2007
6-review
Host-derived interleukin-1alpha is important in determining the immunogenicity of 3-methylcholantrene tumor cells.
PMID 19342666·J Immunol·2009
7-preclinical
Tumorigenicity of IL-1alpha- and IL-1beta-deficient fibrosarcoma cells.
PMID 18516292·Neoplasia·2008
7-preclinical
Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?
PMID 18364005·Immunol Rev·2008
6-review
Opposing effects of fibrosarcoma cell-derived IL-1 alpha and IL-1 beta on immune response induction.
PMID 18412246·Int J Cancer·2008
7-preclinical
Contribution of IL-1 to resistance to Streptococcus pneumoniae infection.
PMID 18596024·Int Immunol·2008
7-preclinical
Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases.
PMID 17900737·J Control Release·2007
7-preclinical
Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors.
PMID 17283139·Cancer Res·2007
7-preclinical
Differential role and tissue specificity of interleukin-1alpha gene expression in atherogenesis and lipid metabolism.
PMID 17173923·Atherosclerosis·2007
7-preclinical
IL-1 beta-deficient mice are resistant to induction of experimental SLE.
PMID 16840029·Eur Cytokine Netw·2006
7-preclinical
The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions.
PMID 17043764·Cancer Metastasis Rev·2006
6-review
Immune phenomena involved in the in vivo regression of fibrosarcoma cells expressing cell-associated IL-1alpha.
PMID 16707560·J Leukoc Biol·2006
7-preclinical
Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions.
PMID 16530403·Eur J Cancer·2006
6-review
CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells.
PMID 16339559·J Immunol·2005
7-preclinical
A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development.
PMID 14597552·FASEB J·2004
7-preclinical
The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription.
PMID 14983027·Proc Natl Acad Sci U S A·2004
7-preclinical
IL-1 is required for tumor invasiveness and angiogenesis.
PMID 12598651·Proc Natl Acad Sci U S A·2003
7-preclinical
Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness.
PMID 14662844·J Immunol·2003
4-observational
Interleukin-1--a major pleiotropic cytokine in tumor-host interactions.
PMID 12147202·Semin Cancer Biol·2002
6-review
Macrophage activation for the production of immunostimulatory cytokines by delivering interleukin 1 via biodegradable microspheres.
PMID 11052820·Cytokine·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 133 E BRUSH HILL RD STE 100
ELMHURST, IL 60126 - Phone
- (630) 967-2225
Quick Facts
- NPI
- 1730170523
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile